{{Rsnum
|rsid=6785504
|Chromosome=3
|position=152954990
|Orientation=plus
|GMAF=0.4738
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 31.0 | 46.9 | 22.1
| HCB | 29.4 | 50.0 | 20.6
| JPT | 27.4 | 46.9 | 25.7
| YRI | 13.6 | 49.7 | 36.7
| ASW | 15.8 | 43.9 | 40.4
| CHB | 29.4 | 50.0 | 20.6
| CHD | 23.9 | 56.0 | 20.2
| GIH | 28.3 | 46.5 | 25.3
| LWK | 17.3 | 50.0 | 32.7
| MEX | 12.1 | 55.2 | 32.8
| MKK | 20.5 | 53.8 | 25.6
| TSI | 26.5 | 45.1 | 28.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21659360
|Trait=None
|Title=Association between SNP-genotype and chronic lymphocytic leukemia outcome in a randomized chemotherapy trial.
|RiskAllele=T
|Pval=0.000007
|OR=2.1100
|ORtxt=[1.51-2.94]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}